Literature DB >> 15876923

Health burden of pertussis in adolescents and adults.

Edward Rothstein1, Kathryn Edwards.   

Abstract

Pertussis in adolescents and adults is common, endemic, and epidemic worldwide, and its incidence is reportedly increasing. Although a number of individuals suffer only a mild cough, many others have symptoms typical of pertussis, causing prolonged cough illness, frequent use of health care resources, missed work and a variety of complications. Symptoms experienced by adolescents and adults include sleep disturbance, weight loss, pharyngeal discomfort, influenza-like symptoms, sneezing attacks, hoarseness, sinus pain, headaches and sweating attacks. Even when symptoms are typical of pertussis, the diagnosis is often not considered in adolescents and adults because of a low awareness of the disease in these age groups. Contrary to common perceptions, complications of pertussis, including some that are serious, are not infrequent in adolescents and adults. These include urinary incontinence, rib fracture, pneumothorax, inguinal hernia, aspiration, pneumonia, seizures and otitis media. Despite underreporting, hospitalization of adults and adolescents does occur. Many believe that adolescents and adults are the groups most commonly infected with pertussis and are now the major source of contagion to infants and young children. Because of the considerable health burden, there is a need for improved vaccination strategies to prevent disease in adolescents and adults and to reduce the risk of transmission to vulnerable infants.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876923     DOI: 10.1097/01.inf.0000160912.58660.87

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  24 in total

1.  Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries.

Authors:  H Broutin; C Viboud; B T Grenfell; M A Miller; P Rohani
Journal:  Proc Biol Sci       Date:  2010-06-09       Impact factor: 5.349

2.  Enhanced surveillance for adverse events following immunization: Two years of dTap catch-up among high school students in Yukon, Canada (2004, 2005).

Authors:  Samara T David; Mhsc Colleen Hemsley; Paula E Pasquali; Bryce Larke; Jane A Buxton; Lee Y Lior
Journal:  Can J Public Health       Date:  2006 Nov-Dec

3.  Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection.

Authors:  Sandra L Menzies; Vijay Kadwad; Lucia C Pawloski; Tsai-Lien Lin; Andrew L Baughman; Monte Martin; Maria Lucia C Tondella; Bruce D Meade
Journal:  Clin Vaccine Immunol       Date:  2009-10-28

4.  Shift in the epidemiology of pertussis infection: an indication for pertussis vaccine boosters for adults?

Authors:  Sylvia H Yeh; ChrisAnna M Mink
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Reduced Bordetella pertussis-specific CD4+ T-Cell Responses at Older Age.

Authors:  Eleonora E Lambert; Inonge van Twillert; Lisa Beckers; Martien C M Poelen; Wanda G H Han; Daan K J Pieren; Cécile A C M van Els
Journal:  Front Aging       Date:  2022-02-02

Review 6.  Symptomatic treatment of the cough in whooping cough.

Authors:  Kay Wang; Silvana Bettiol; Matthew J Thompson; Nia W Roberts; Rafael Perera; Carl J Heneghan; Anthony Harnden
Journal:  Cochrane Database Syst Rev       Date:  2014-09-22

7.  JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG.

Authors:  Keiichi Mikasa; Nobuki Aoki; Yosuke Aoki; Shuichi Abe; Satoshi Iwata; Kazunobu Ouchi; Kei Kasahara; Junichi Kadota; Naoki Kishida; Osamu Kobayashi; Hiroshi Sakata; Masahumi Seki; Hiroki Tsukada; Yutaka Tokue; Fukumi Nakamura-Uchiyama; Futoshi Higa; Koichi Maeda; Katsunori Yanagihara; Koichiro Yoshida
Journal:  J Infect Chemother       Date:  2016-06-15       Impact factor: 2.211

8.  Epidemiology of pertussis among adolescents, adults, and older adults in selected countries of Latin American: a systematic review.

Authors:  Altacilio Nunes; Ariane Abreu; Bárbara Furtado; Anderson Soares da Silva; Eduardo B Coelho; Eliana Nc de Barros
Journal:  Hum Vaccin Immunother       Date:  2021-03-18       Impact factor: 3.452

9.  Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model.

Authors:  Robin de Vries; Mirjam Kretzschmar; Joop F P Schellekens; Florens G A Versteegh; Tjalke A Westra; John J Roord; Maarten J Postma
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

10.  Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients.

Authors:  Naoyuki Miyashita; Hiroto Akaike; Hideto Teranishi; Yasuhiro Kawai; Kazunobu Ouchi; Tadashi Kato; Toshikiyo Hayashi; Niro Okimoto
Journal:  BMC Infect Dis       Date:  2013-03-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.